BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Enhancer of zeste homolog 2 (EZH2)

December 17, 2015 8:00 AM UTC

Cell culture and mouse studies suggest inhibiting EZH2 phosphorylation could help treat drug-resistant MM. In a human cell-based model of doxorubicin-resistant MM, knockdown of kinases that phosphoryl...